Could increasing the duration of triple therapy be a clinically useful strategy?

Ann Intern Med. 2008 Apr 15;148(8):624; author reply 624-5. doi: 10.7326/0003-4819-148-8-200804150-00009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Data Interpretation, Statistical
  • Drug Administration Schedule
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Proton Pump Inhibitors*

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors